Amyloid beta pathology in Alzheimer's disease and schizophrenia.

@article{Religa2003AmyloidBP,
  title={Amyloid beta pathology in Alzheimer's disease and schizophrenia.},
  author={Dorota Religa and Hanna Laudon and Maria Styczyńska and Bengt Winblad and Jan N{\"a}slund and Vahram H Haroutunian},
  journal={The American journal of psychiatry},
  year={2003},
  volume={160 5},
  pages={867-72}
}
OBJECTIVE Severe cognitive impairment is common in elderly patients with schizophrenia. Alzheimer's disease is the main cause of dementia among the elderly. Biochemical and genetic studies suggest that amyloid beta-peptide is central in Alzheimer's disease. The authors examined the possible involvement of amyloid beta-peptide in cognitive impairment in… CONTINUE READING